Acquired haemophilia A: A 2013 update

作者: Massimo Franchini , Pier Mannucci

DOI: 10.1160/TH13-05-0363

关键词:

摘要: Acquired haemophilia A (AHA) is a rare but often severe bleeding disorder caused by autoantibodies against coagulation factor VIII (FVIII). AHA occurs more frequently in the elderly and association with several conditions, such as post-partum period, malignancies, autoimmune diseases or drug exposure; however, approximately 50% of reported cases are apparently idiopathic. Beside elimination underlying disorder, therapeutic approach to should be directed toward control acute bleed eradication FVIII autoantibody production. In this narrative review, we summarise current knowledge on epidemiology, diagnosis clinical features AHA, focusing particular advances management challenging disorder.

参考文章(98)
David Green, Klaus Lechner, A survey of 215 non-hemophilic patients with inhibitors to Factor VIII. Thrombosis and Haemostasis. ,vol. 45, pp. 200- 203 ,(1981) , 10.1055/S-0038-1650169
C R M Hay, C Negrier, C A Ludlam, The treatment of bleeding in acquired haemophilia with recombinant factor VIIa: a multicentre study. Thrombosis and Haemostasis. ,vol. 78, pp. 1463- 1467 ,(1997) , 10.1055/S-0038-1665434
Giuseppe Lippi, Massimo Franchini, The use of desmopressin in acquired haemophilia A: a systematic review. Blood Transfusion. ,vol. 9, pp. 377- 382 ,(2011) , 10.2450/2011.0113-10
T. Papo, P. Godeau, B. Wechsler, P. Meekel, V. Le Moing, S. Vignes, Acquired hemophilia: a rare complication of Sjögren's syndrome. Clinical and Experimental Rheumatology. ,vol. 14, pp. 559- 560 ,(1996)
AE Morrison, CA Ludlam, C Kessler, Use of porcine factor VIII in the treatment of patients with acquired hemophilia Blood. ,vol. 81, pp. 1513- 1520 ,(1993) , 10.1182/BLOOD.V81.6.1513.1513
J. OLDENBURG, H. ZEITLER, A. PAVLOVA, Genetic markers in acquired haemophilia. Haemophilia. ,vol. 16, pp. 41- 45 ,(2010) , 10.1111/J.1365-2516.2010.02259.X